The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Galapagos NV(NASDAQ:GLPG) 
Galapagos NV, a clinical-stage biotechnology company, discovers, develops, and commercializes various small molecule medicines. Its clinical stage programs include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ul...
Website: http://www.glpg.com
Founded: 1999
Full Time Employees: 1,407
Sector: Healthcare
Industry: Biotechnology
Galapagos NV Days Payable Outstanding ttm (DPO)
Galapagos NV Days Receivable Outstanding ttm (DSO)
Galapagos NV Days Inventory Outstanding ttm (DIO)
Galapagos NV Op Cashflow Per Share ttm
Galapagos NV Free Cashflow Per Share ttm
Galapagos NV Cash Per Share ttm
Galapagos NV P/S ratio ttm
Galapagos NV (GAAP) P/E ratio ttm
Galapagos NV P/B ratio ttm
No extra charts and metrics for this ticker.